PLK1 and cancer: Our results indicate that the increased abundance and activity of PLK1 in cancer may not be restricted to dysfunction in the classical role of PLK1 in the cell cycle, but can also lead to an upregulation in the expression of ARE‐coding genes, including pro‐inflammatory, chemotactic, and metastatic players.